The IKZF1 N159S mutation is associated with poor outcome and a distinct molecular profile in adult patients with AML

IKZF1 mutations are recurrent alterations in acute myeloid leukaemia (AML), and hotspot point mutation, N159S, has recently been associated with unique gene expression and adverse risk. To better understand the molecular and clinical associations of IKZF1 N159S-mutated AML, we performed a pooled ana...

Full description

Saved in:
Bibliographic Details
Main Authors: Stasik, Sebastian (Author) , Eckardt, Jan-Niklas (Author) , Röllig, Christoph (Author) , Baldus, Claudia (Author) , Platzbecker, Uwe (Author) , Serve, Hubert (Author) , Müller-Tidow, Carsten (Author) , Schäfer-Eckart, Kerstin (Author) , Kaufmann, Martin (Author) , Krause, Stefan W. (Author) , Sauer, Tim (Author) , Hänel, Mathias (Author) , Neubauer, Andreas (Author) , Ehninger, Gerhard (Author) , Bornhäuser, Martin (Author) , Schetelig, Johannes (Author) , Middeke, Jan M. (Author) , Thiede, Christian (Author)
Format: Article (Journal)
Language:English
Published: May 2025
In: British journal of haematology
Year: 2025, Volume: 206, Issue: 5, Pages: 1373-1379
ISSN:1365-2141
DOI:10.1111/bjh.20027
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1111/bjh.20027
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.20027
Get full text
Author Notes:Sebastian Stasik, Jan-Niklas Eckardt, Christoph Röllig, Claudia D. Baldus, Uwe Platzbecker, Hubert Serve, Carsten Müller-Tidow, Kerstin Schäfer-Eckart, Martin Kaufmann, Stefan W. Krause, Tim Sauer, Mathias Hänel, Andreas Neubauer, Gerhard Ehninger, Martin Bornhäuser, Johannes Schetelig, Jan M. Middeke, Christian Thiede, on behalf of the Study Alliance Leukemia (SAL)
Description
Summary:IKZF1 mutations are recurrent alterations in acute myeloid leukaemia (AML), and hotspot point mutation, N159S, has recently been associated with unique gene expression and adverse risk. To better understand the molecular and clinical associations of IKZF1 N159S-mutated AML, we performed a pooled analysis of 4136 AML patients. IKZF1 N159 mutations were found in 39 patients (0.94%) in a dominant clonal constellation, indicating early genetic events. N159S mutations were associated with aberrant karyotype, significantly higher rates of myelodysplasia-related gene mutations, ELN2022 adverse risk and a particularly poor outcome, supporting the classification of IKZF1 N159S-mutated AML as a rare molecular subtype with adverse prognosis.
Item Description:Online verfügbar: 05. März 2025
Gesehen am 04.09.2025
Physical Description:Online Resource
ISSN:1365-2141
DOI:10.1111/bjh.20027